Literature DB >> 9259177

Drugs for the treatment of impotence.

L Garcia-Reboll1, J P Mulhall, I Goldstein.   

Abstract

Penile erection is a complex neurovascular event that represents a balance between corporal smooth muscle relaxation and contraction. This balance is determined by the interaction between proerectile and antierectile neurotransmitters. It is believed that nitric oxide is the primary erectogenic neurotransmitter and that noradrenaline (norepinephrine) is the primary erectolytic neurotransmitter. There are a number of pharmacological approaches to the management of erectile dysfunction and manipulation of the neurotransmitter systems. These involve direct delivery of drugs into the erectile chambers (intracavernosal injection therapy), administration of medications into the urethra (transurethral delivery), application of medications to the skin (transdermal delivery) and it is hoped that oral agents will be available in the very near future. This article reviews the world literature on the medications that have been investigated to date and their delivery routes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259177     DOI: 10.2165/00002512-199711020-00006

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  86 in total

1.  Nitric oxide: a physiologic mediator of penile erection.

Authors:  A L Burnett; C J Lowenstein; D S Bredt; T S Chang; S H Snyder
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

2.  The effects of intracranial administration of the dopamine agonist apomorphine on penile reflexes and seminal emission in the rat.

Authors:  E A Pehek; J T Thompson; E M Hull
Journal:  Brain Res       Date:  1989-10-23       Impact factor: 3.252

3.  Adrenergic alpha receptors outnumber beta receptors in human penile corpus cavernosum.

Authors:  R M Levin; A J Wein
Journal:  Invest Urol       Date:  1980-11

4.  Intracavernous injection of prostaglandin E1 in impotent men.

Authors:  W Stackl; R Hasun; M Marberger
Journal:  J Urol       Date:  1988-07       Impact factor: 7.450

5.  Nitric oxide synthase: a new diagnostic tool for neurogenic impotence.

Authors:  G Brock; L Nunes; H Padma-Nathan; S Boyd; T F Lue
Journal:  Urology       Date:  1993-10       Impact factor: 2.649

6.  Anatomical distribution and ultrastructural organization of the GABAergic system in the rat spinal cord. An immunocytochemical study using anti-GABA antibodies.

Authors:  R Magoul; B Onteniente; M Geffard; A Calas
Journal:  Neuroscience       Date:  1987-03       Impact factor: 3.590

7.  Cholinergic neurotransmission in human corpus cavernosum. II. Acetylcholine synthesis.

Authors:  R Blanco; I Saenz de Tejada; I Goldstein; R J Krane; H H Wotiz; R A Cohen
Journal:  Am J Physiol       Date:  1988-03

8.  Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum.

Authors:  P A Bush; W J Aronson; G M Buga; J Rajfer; L J Ignarro
Journal:  J Urol       Date:  1992-06       Impact factor: 7.450

9.  Priapism of the clitoris: a case report following trazodone use.

Authors:  E S Pescatori; J C Engelman; G Davis; I Goldstein
Journal:  J Urol       Date:  1993-06       Impact factor: 7.450

10.  Role of the dopaminergic, serotonergic and cholinergic link in the expression of penile erection in rats.

Authors:  N Maeda; N Matsuoka; I Yamaguchi
Journal:  Jpn J Pharmacol       Date:  1994-09
View more
  1 in total

1.  Men's aging and sexual disorders: an update on diagnosis and treatment.

Authors:  Alvaro Morales
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.